biotech.today

Details

  • ●Modalities: small molecules
  • ●Therapeutic areas: oncology
  • ●Key targets: MALT1, CDC7
  • ●Indications: Undisclosed
  • ●Funding: $2.7B

Partners & investors

  • BMS· Investor
  • Novartis· Investor

Key considerations

  • ●AI tools in use: Glide, FEP+, Desmond, LiveDesign
  • ●Nasdaq IPO 2020
  • ●BMS $2.7B biobucks deal
  • ●Novartis partnership

Pipeline

  • Phase 11
Get live updates on Schrödinger’s hiring, filings, and partnerships. Follow in BT Pro →
Source: Company website, SEC / Companies House filings, press releases, Crunchbase · biotech.today analysis (Apr 2026)

Key people

Ramy Farid

President & CEO

computational-chemistryfepphysics-based-simulation
Visit website →LinkedIn →